Brief: Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition
19/06/2026 03:55
BRIEF-Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition June 19 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - UNIT TO BUY 100% OF LANNETT COMPANY
AUROBINDO PHARMA - OBTAINS US FTC APPROVAL FOR LANNETT ACQUISITION
AUROBINDO PHARMA - EXPECTS LANNETT DEAL TO CLOSE BEFORE END OF JUNE 2026
Source text: ID:nBSE51F0Jx
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma USA Receives FTC Approval To Acquire Lannett Company
Brief: Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett (updated)
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett Company Inc.
HSBC sees no earnings hit from FDA action on India's Aurobindo Pharma